search
Back to results

A Trial of Fast Access to Transvaginal Ultrasound Through General Practice for Earlier Diagnosis of Ovarian Cancer

Primary Purpose

Ovarian Cancer

Status
Completed
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
Transvaginal ultrasound
Sponsored by
University of Aarhus
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Ovarian Cancer focused on measuring Transvaginal ultrasound, General practice, Early diagnosis, Symptoms

Eligibility Criteria

40 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • GPs in the Central Denmark Region
  • Women ≥40 years presenting with vague and non-specific symptoms

Exclusion Criteria:

  • Women who fulfil access criteria for OC fast-track referral.

Sites / Locations

  • Aarhus University

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Intervention

Arm Description

All GPs in Central Denmark Region, are planned to be enrolled in the study during the one year study period.

Outcomes

Primary Outcome Measures

Frequency of TVU use
TVU will be requested electronically through an online referral-system used by Danish GPs. This outcome will be evaluated descriptively by illustrating the relation between time and use of TVU.
Action taken on test results
After all TVU investigations, a discharge summary will be send electronically to the referring GP. If indicated, instructions for follow-up investigations is stated in the discharge summary. To evaluate if GPs follow these instructions, data on discharge summary recommended follow-up are compared to data on follow-up referrals made by the GPs. This outcome will be evaluated descriptively.
Patient-reported symptoms before TVU investigation
All women who are referred to TVU will receive a questionnaire prior to investigation, regarding experienced symptoms during the past year.
Indication for fast TVU
GPs refer women to TVU electronically. Information about indications for the investigation, is required in the referral. These informations will be used to evaluate the GPs reasons for referring the women to TVU and will be evaluated descriptively.

Secondary Outcome Measures

Findings by TVU on women with vague and non-specific symptoms
An overview of all findings by TVU will be provided, and possible side effects will be assessed. An algorithm for the use of TVU has been developed, and the principal investigator will tick a box specifying what has been discovered during the investigation. Findings by TVU is identified in the algorithm used for TVU and by ICD-10 codes.
Ovarian Cancer (OC) stage distribution
Number of OC diagnosed in each cancer stage (FIGO I-IV)

Full Information

First Posted
February 22, 2017
Last Updated
April 1, 2020
Sponsor
University of Aarhus
search

1. Study Identification

Unique Protocol Identification Number
NCT03069872
Brief Title
A Trial of Fast Access to Transvaginal Ultrasound Through General Practice for Earlier Diagnosis of Ovarian Cancer
Official Title
Access to Fast Transvaginal Ultrasound Through General Practice for Earlier Diagnosis of Ovarian Cancer
Study Type
Interventional

2. Study Status

Record Verification Date
April 2018
Overall Recruitment Status
Completed
Study Start Date
April 5, 2017 (Actual)
Primary Completion Date
April 30, 2018 (Actual)
Study Completion Date
April 30, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Aarhus

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Background Ovarian cancer (OC) is a disease with a poor prognosis due to diagnosis at late stage. Early-stage OC presents with non-specific and vague symptoms and therefore OC usually is not detected until reaching an advanced stage. From 2008, Danish general practitioners (GPs) could urgently refer patients suspected of having OC to standardized cancer patient pathways (CPPs). The CPP is designed for women presenting specific signs and alarm symptoms, and is supposed to shorten the pathway from suspicion to treatment. Hypothesis Direct access to fast transvaginal ultrasound (TVU) through general practice is feasible in earlier diagnosis of OC. Aim The aim of this study is to assess the implementation and clinical implications of direct referral access to fast TVU through general practice. Materials and methods The study is a feasibility study and GPs from in Central Denmark Region are offered direct access to fast TVU for women aged 40 years or more who present symptoms that could origin from OC, but which are not classified as alarm symptoms. The GPs will receive education about updated knowledge on OC symptoms and the use of the guideline for earlier diagnosis of OC in general practice. The study period is 1 year. Perspectives There is a great need to test rational strategies for diagnosing OC at an earlier stage in order to improve survival. For women who do not fulfil access criteria for the CPP, and for whom the main prospect for earlier diagnosis is improved identification of symptomatic OC, this study may provide important new knowledge of how to facilitate the diagnostics of OC in the future and reduce time to diagnosis and improve survival.
Detailed Description
Background Around 550 ovarian cancers (OCs) are diagnosed yearly in Denmark. Still, OC is the fourth commonest cause of cancer death amongst women in Denmark. Epithelial ovarian cancers (carcinomas) account for more than 90% of all OCs and Denmark has the second highest incidence in the world (15 per 100.000 women) with a life-time risk around 2%. The mean age at diagnosis is 63 years, and 80% are postmenopausal. In Denmark, 74% are diagnosed in FIGO stage III-IV and therefore at the time of diagnosis have regional or metastatic spread. Five-year survival with FIGO stage I is 83%, stage II 62%, stage III 23% and stage IV 11%. Thus, OC is detected at advanced stages with a very poor prognosis. In 2008, a national fast-track system for cancer patients was established to ensure fast diagnosis and initiation of treatment. The fast-track system or cancer patient pathway (CPP) implies that patients presenting 'alarm' symptoms of e.g. OC will be referred immediately for diagnostic workup; no more than 14 days must pass from referral to initiation of treatment. Only about one quarter of the women with OC are referred primarily through this route. Therefore, additional accelerated routes are needed for the majority of women with OC. A possibility could be access to fast TVU through general practice for women presenting with vague and non-specific symptoms that may represent underlying OC. Aim Develop and conduct training for general practitioners (GPs) in the latest knowledge of OC symptomatology. And at the same time investigate the feasibility and clinical implications in general practice of direct referral access to fast TVU, intended for women presenting with vague and non-specific symptoms. Material and methods GPs in Central Denmark Region are offered direct access to fast TVU for women aged 40 years or more who present vague and non-specific symptoms that could origin from OC, but which are not classified as alarm symptoms. Shortly afterwards all the GPs are offered a short lecture on OC symptomatology and instructions for the use of TVU for earlier diagnosis of OC through general practice. The lecture will be conducted by researchers from the research group. Prior to investigation, all women who are referred to TVU will receive a consent form and a symptom-questionnaire. The symptom questionnaire focuses on the experienced symptoms during the past year. After finished investigation, the TVU test results will return electronically to the referring GP. The study period is one year. Data analysis will focus on the frequency of TVU use in general practice, action taken on test results and patient-reported symptoms prior to TVU. Perspectives The project will provide important new knowledge of the GPs referral practice when they suspect OC. For women presenting with vague and non-specific symptoms that may origin from OC, the introduction of TVU through general practice will provide new possibilities for evaluating the symptoms. Therefor introduction of TVU is a corner stone in the identification of more efficient ways to evaluate women at risk of developing OC. This study will contribute with important knowledge of how to improve the diagnostics of OC in the future and may reduce time to diagnosis.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Ovarian Cancer
Keywords
Transvaginal ultrasound, General practice, Early diagnosis, Symptoms

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
490 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Intervention
Arm Type
Experimental
Arm Description
All GPs in Central Denmark Region, are planned to be enrolled in the study during the one year study period.
Intervention Type
Diagnostic Test
Intervention Name(s)
Transvaginal ultrasound
Intervention Description
Access to fast transvaginal ultrasound through general practice Develop and conduct training for general practicioners in the latest knowledge of ovarian cancer symptomatology
Primary Outcome Measure Information:
Title
Frequency of TVU use
Description
TVU will be requested electronically through an online referral-system used by Danish GPs. This outcome will be evaluated descriptively by illustrating the relation between time and use of TVU.
Time Frame
one year
Title
Action taken on test results
Description
After all TVU investigations, a discharge summary will be send electronically to the referring GP. If indicated, instructions for follow-up investigations is stated in the discharge summary. To evaluate if GPs follow these instructions, data on discharge summary recommended follow-up are compared to data on follow-up referrals made by the GPs. This outcome will be evaluated descriptively.
Time Frame
one year
Title
Patient-reported symptoms before TVU investigation
Description
All women who are referred to TVU will receive a questionnaire prior to investigation, regarding experienced symptoms during the past year.
Time Frame
one year
Title
Indication for fast TVU
Description
GPs refer women to TVU electronically. Information about indications for the investigation, is required in the referral. These informations will be used to evaluate the GPs reasons for referring the women to TVU and will be evaluated descriptively.
Time Frame
one year
Secondary Outcome Measure Information:
Title
Findings by TVU on women with vague and non-specific symptoms
Description
An overview of all findings by TVU will be provided, and possible side effects will be assessed. An algorithm for the use of TVU has been developed, and the principal investigator will tick a box specifying what has been discovered during the investigation. Findings by TVU is identified in the algorithm used for TVU and by ICD-10 codes.
Time Frame
one year
Title
Ovarian Cancer (OC) stage distribution
Description
Number of OC diagnosed in each cancer stage (FIGO I-IV)
Time Frame
one year

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: GPs in the Central Denmark Region Women ≥40 years presenting with vague and non-specific symptoms Exclusion Criteria: Women who fulfil access criteria for OC fast-track referral.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Marie-Louise L Baun, MD
Organizational Affiliation
Research Unit of General Practice, Aarhus University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Peter Vedsted, Professor
Organizational Affiliation
Research Unit of General Practice, Aarhus University
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Margit Dueholm, As.Professor
Organizational Affiliation
Department of Gynaecology and Obstetrics, Aarhus University Hospital
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Lone Kjeld Petersen, As.Professor
Organizational Affiliation
Department of Gynaecology, Randers Regional Hospital
Official's Role
Study Chair
Facility Information:
Facility Name
Aarhus University
City
Aarhus
State/Province
Region Midt
ZIP/Postal Code
8000
Country
Denmark

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

A Trial of Fast Access to Transvaginal Ultrasound Through General Practice for Earlier Diagnosis of Ovarian Cancer

We'll reach out to this number within 24 hrs